When a child or young adult is diagnosed with cancer, the experience reverberates far beyond the hospital walls—reshaping families, communities, and the future itself. Yet the scientific and medical knowledge devoted specifically to these younger patients has long been scattered across diverse disciplines and publications. In response to this critical gap, the American Cancer Society is launching a new journal dedicated exclusively to pediatric, adolescent, and young adult oncology, and has appointed its inaugural Editor-in-Chief to guide the publication’s vision and voice. This new journal promises to serve as a focused forum where cutting-edge research, clinical innovation, and multidisciplinary perspectives converge to improve outcomes for some of the most vulnerable people facing cancer.
Introducing a new era in oncology communication for young patients and their care teams
The launch of this specialized journal marks a bold step toward reshaping how clinicians, researchers, young patients, and families share and interpret critical information about cancer. By focusing on pediatric, adolescent, and young adult experiences, it provides a dedicated space where age-specific challenges, from biology to psychosocial impact, are not an afterthought but the central narrative. The newly appointed Editor-in-Chief brings a unifying vision: to connect cutting-edge science with everyday realities in exam rooms, infusion centers, and living rooms across the world.
More than a repository of studies, the journal is designed as a dynamic resource for the people behind the data. Articles will be crafted to inform not only oncologists and nurses, but also social workers, educators, and advocacy leaders who stand alongside young patients. Through collaborative features such as:
- Translational summaries that turn complex findings into clear, actionable insights
- Patient and survivor perspectives integrated into clinical discussions
- Practice-oriented checklists to support real-time decision-making
- Digital-first tools tailored to mobile, telehealth, and school-based care
the publication aims to close the gap between discovery and day-to-day care.
| Focus Area | Who It Serves | What Readers Gain |
|---|---|---|
| Early diagnosis & risk | Pediatric & AYA clinicians | Faster pathways to detection |
| Treatment innovations | Care teams & researchers | Evidence to refine protocols |
| Quality of life & survivorship | Patients, families, advocates | Strategies for life during and after cancer |
| Equity & access | Health systems & policymakers | Models to reduce disparities |
Defining the journal mission advancing research for pediatric adolescent and young adult cancers
The new publication is conceived as a dedicated, interdisciplinary platform where discoveries across the spectrum of childhood, adolescent, and young adult malignancies can converge, accelerate, and translate into better outcomes. By emphasizing rigor, transparency, and ethical integrity, the journal will champion studies that illuminate the unique biology, clinical trajectories, psychosocial dimensions, and survivorship needs of younger patients. Equally important, it will prioritize work that bridges the lingering gaps between pediatric and adult oncology, fostering a continuum of knowledge that follows patients as they grow, transition, and thrive.
To make a tangible impact on care, the journal will actively seek research that is not only statistically sound, but also swiftly translatable to the bedside, the classroom, and the community. Submissions will be welcomed from a broad range of disciplines, including oncology, psychology, nursing, epidemiology, health policy, genomics, and implementation science. Key areas of emphasis will include:
- Precision and targeted therapies tailored to developing bodies and maturing immune systems
- Equity-focused studies that confront disparities in access, outcomes, and clinical trial participation
- Quality-of-life research spanning diagnosis, treatment, survivorship, and late effects
- Innovative trial designs that reflect real-world practice and rare disease realities
- Supportive and palliative care that centers families, caregivers, and communities
By elevating diverse voices and methodologies, the journal aims to set a new benchmark for impact and inclusivity within this field. Strategic editorial priorities will guide the selection of content most likely to reshape standards of care and inform policy deliberations at local, national, and global levels. In collaboration with clinicians, scientists, and advocates, the publication will serve as a catalyst for sustained progress, helping to transform promising data into concrete improvements in prevention, diagnosis, therapy, survivorship, and long-term well-being.
Spotlight on the inaugural editor in chief leadership vision and scientific priorities
The journal’s founding editor is shaping a bold roadmap that bridges discovery with real-world impact for children, adolescents, and young adults facing cancer. Drawing on a deep understanding of developmental biology, survivorship, and health equity, the editorial direction emphasizes research that not only advances cures, but also protects growth, identity, and long-term wellbeing. Under this leadership, the journal will prioritize work that challenges entrenched assumptions, integrates voices across disciplines, and confronts the unique vulnerabilities of this population—from late effects of therapy to the psychosocial complexities of transitioning between pediatric and adult care.
To catalyze meaningful change, the editorial strategy focuses on a curated mix of high-impact science and practice-shaping insights, with an emphasis on:
- Translational pipelines that connect molecular discoveries to therapeutic trials in younger patients.
- Innovative trial designs suitable for rare cancers and small, age-specific cohorts.
- Survivorship and quality of life research that informs life-long monitoring and support.
- Implementation science to close gaps between evidence and routine care around the world.
- Health equity initiatives that address disparities by geography, race, ethnicity, gender identity, and socioeconomic status.
| Leadership Pillar | Editorial Focus |
|---|---|
| Vision | Unify pediatric, adolescent, and young adult oncology in a single, dynamic forum. |
| Innovation | Highlight first-in-field studies, novel technologies, and adaptive care models. |
| Collaboration | Promote cross-disciplinary teams, patient-partnered research, and global networks. |
| Impact | Prioritize research with clear pathways to policy, guidelines, and bedside change. |
Bridging the gaps translating cutting edge discoveries into everyday clinical practice
With the launch of this new journal, the American Cancer Society creates a dedicated home for ideas that have long been stranded between the laboratory bench and the bedside. Under the guidance of the Editor-in-Chief, the editorial vision is to spotlight work that does more than prove a concept—it shows clinicians, nurses, and allied health professionals how to use it today for children, adolescents, and young adults. This means elevating studies that translate molecular insights into practical protocols, feature real-world implementation data, and acknowledge the messy complexity of everyday oncology practice.
To support this, the journal will emphasize pragmatic research designs, cross-disciplinary dialogue, and tools that make innovation usable, not just admirable. Authors will be encouraged to pair novel findings with:
- Clear clinical pathways that outline how care teams can adapt new evidence
- Decision aids for shared choices with patients and families
- Implementation checklists tailored to diverse care settings
- Brief training resources for clinicians in busy pediatric and AYA clinics
| Discovery | Clinical Question | Practice Impact |
|---|---|---|
| Genomic risk profiles | Which patients truly need intensive therapy? | More precise, less toxic regimens |
| Immunotherapy insights | How can novel agents fit into existing protocols? | Expanded options after relapse |
| Digital symptom monitoring | Can remote tools reduce emergency visits? | Earlier interventions, smoother survivorship |
Empowering families and survivors integrating psychosocial support into cancer care
In the evolving landscape of pediatric, adolescent, and young adult oncology, emotional well‑being is no longer an optional add‑on—it is a core component of quality care. The newly launched journal creates space for research and narratives that recognize children, teens, and young adults not just as patients, but as students, siblings, friends, and dreamers navigating an altered life course. By elevating studies on mood, resilience, family communication, body image, and post‑treatment identity, this platform invites clinicians and researchers to design care pathways where chemotherapy infusions can coexist with counseling sessions, and where survivorship plans automatically include mental health follow‑ups and social reintegration strategies.
For families, this shift means that their fears, financial strain, and day‑to‑day exhaustion become visible data points worthy of study and action rather than private burdens carried in silence. Articles and case reports are expected to highlight how parents, grandparents, and siblings adapt, cope, and advocate, transforming lived experience into practical frameworks that can be used in clinics, schools, and community programs. Within this context, psychosocial teams—social workers, psychologists, child‑life specialists, and peer navigators—are not peripheral; they are integrated collaborators who stand alongside oncologists in treatment planning and decision‑making.
By foregrounding supportive care, the journal encourages multidisciplinary models that are responsive to the diverse realities of young people and their caregivers. Research on digital peer communities, culturally attuned counseling, and school re‑entry programs can guide hospitals in building services that feel relatable and accessible. Families and survivors gain tools to voice their priorities, from preserving fertility and educational goals to managing anxiety and late effects, helping shape a care ecosystem grounded in dignity, autonomy, and long‑term quality of life.
Strengthening collaboration uniting researchers clinicians and advocacy communities
At the heart of this new journal is a commitment to bring every voice that matters around the same table—those who search for answers in the lab, those who deliver care at the bedside, and those who live the stories behind every statistic. By embracing a collaborative publishing model, the journal will prioritize submissions that emerge from cross-disciplinary teams and shared data initiatives, encouraging researchers, clinicians, and advocacy partners to co-author work that bridges the gaps between discovery, implementation, and lived experience. This approach is designed to move promising insights more quickly from preliminary findings to practical tools that can transform how pediatric, adolescent, and young adult cancer is prevented, diagnosed, treated, and followed long term.
To support this ecosystem, the journal will spotlight projects that are built on genuine partnership, not just consultation. Submissions will be encouraged to demonstrate how diverse stakeholders have shaped the research question, design, and dissemination plan. The journal will highlight:
- Multi-institution studies that integrate academic centers, community hospitals, and survivorship clinics
- Advocacy-led initiatives that identify overlooked needs or inequities in care
- Practice-changing protocols co-developed by clinicians and patient advisors
- Data- and biospecimen-sharing networks specifically tailored to rare pediatric and AYA cancers
| Community | Core Contribution | Journal Opportunity |
|---|---|---|
| Researchers | Generate evidence and innovation | Publish trials, translational work, and methods |
| Clinicians | Transform evidence into care | Share real-world outcomes and care models |
| Advocacy Groups | Define priorities and amplify needs | Co-create perspectives, policy briefs, and reports |
Through this intentional structure, the journal aims to turn isolated efforts into a coordinated movement where insight travels in every direction—bench to bedside, bedside to community, and community back to research—reshaping what progress looks like for young people facing cancer.
How clinicians can engage submission guidelines peer review expectations and future calls for papers
Clinicians interested in contributing to this new journal are encouraged to familiarize themselves early with the author resources, which outline formatting, ethical standards, and reporting requirements specific to pediatric, adolescent, and young adult oncology. Manuscripts that clearly address age-specific biology, survivorship concerns, or disparities in care will be prioritized, and authors should highlight these elements in their abstracts and cover letters. To streamline preparation, contributors can draw on journal-approved templates for original research, case series, qualitative work, and implementation studies, ensuring that submissions are both scientifically rigorous and accessible to an interdisciplinary readership.
- Manuscript types: Original research, brief reports, clinical trials, case reports, reviews, perspectives
- Key requirements: Clear methodology, adherence to CONSORT/STROBE/PRISMA when applicable, robust statistics
- Ethics: IRB approval, assent and consent processes tailored to minors and young adults, data privacy safeguards
- Presentation: Plain-language summary for families, visual abstracts encouraged for complex findings
| Peer Review Focus | What Clinicians Should Provide |
|---|---|
| Scientific validity | Transparent design, sample size rationale, limitations |
| Patient impact | Clear clinical implications and practice-ready recommendations |
| Equity & access | Data on diverse populations, attention to structural barriers |
| Family-centered care | Inclusion of psychosocial outcomes and survivorship planning |
Looking ahead, the journal will issue themed calls for papers that invite clinicians to move beyond traditional trial reports and share real-world innovations in care delivery, supportive care models, and survivorship pathways. Upcoming opportunities may include special issues on AYA engagement in clinical trials, genomics in frontline therapy, and transition from pediatric to adult oncology services. Clinicians can subscribe to alerts or follow the journal’s digital channels to receive timely notices about these calls and should consider collaborating across disciplines to submit multi-institutional work that reflects the full continuum of care—from diagnosis through long-term survivorship and late effects management.
The Conclusion
As this new journal prepares to accept its first submissions, it stands at the intersection of science, care, and hope for young people facing cancer. By uniting researchers, clinicians, advocates, and survivors under a single, focused platform—guided by the vision of its inaugural Editor-in-Chief—the American Cancer Society signals a renewed commitment to this often-overlooked community.
In the months and years ahead, the true measure of this endeavor will lie not only in impact factors or citation counts, but in the clarity it brings to unanswered questions and the options it opens for patients and families. For now, the launch marks a deliberate step toward a future in which pediatric, adolescent, and young adult cancers are studied with the depth, urgency, and nuance they demand—one carefully reviewed article at a time.
